Reviva Pharmaceuticals I... (RVPH)
NASDAQ: RVPH
· Real-Time Price · USD
0.35
-0.41 (-54.17%)
At close: Jun 26, 2025, 3:59 PM
Reviva Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -29.92M | -33.38M | -36.36M | -40.95M | -40.12M | -38.51M | -30.68M | -23.58M | -24.34M | -19.91M | -18.67M | -14.94M | -8.52M | -6.36M | -4.74M | -3.98M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 107.00 | 269.00 | 430.00 |
Stock-Based Compensation | 1.63M | 1.47M | 1.47M | 3.73M | 3.41M | 3.08M | 2.77M | 188.58K | 176.74K | 182.18K | 169.19K | 129.31K | 89.62K | 27.59K | n/a | n/a |
Other Working Capital | -6.83M | -4.11M | -1.55M | 2.46M | 9.2M | 8.78M | 6.17M | 2.18M | 2M | 337.49K | 701.14K | 975.63K | -203.71K | -1.94M | -3.94M | -3.96M |
Other Non-Cash Items | -717.64K | -795.53K | -862.28K | -205.84K | 239.22K | 767.71K | 906.79K | 272.59K | 194.71K | -505.26K | -705.53K | -699.57K | -1.53M | -34.34K | 1.29M | 1.01M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -4.54M | -607.33K | 499.35K | 5.32M | 8.14M | 10.52M | 5.04M | 2.47M | 5.01M | 2.06M | 2.73M | 1.69M | -702.17K | -2.99M | -4.32M | -3.81M |
Operating Cash Flow | -33.54M | -33.32M | -35.26M | -32.1M | -28.32M | -24.14M | -21.96M | -20.65M | -18.96M | -18.17M | -16.48M | -13.82M | -10.67M | -9.36M | -7.77M | -6.78M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.77M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.77M |
Debt Repayment | 582.65K | -15K | -15K | 109.5K | -222.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.68M | 2.68M | 2.81M | n/a | 687.09K | -7.77B | -7.77B | -7.77B | -7.77B | 61.35K | -546.58K | 30.95M | 30.95M | 42.23M | 43.71M | 12.6M |
Financial Cash Flow | 23.65M | 33.91M | 30.28M | 32.82M | 33.17M | 5.92M | 13.69M | 8.48M | 7.79M | 7.87M | -511.45K | 30.99M | 30.99M | 42.23M | 43.71M | 12.6M |
Net Cash Flow | -9.89M | 586.52K | -4.97M | 718.1K | 4.85M | -18.22M | -8.27M | -12.17M | -11.17M | -10.3M | -16.38M | 17.78M | 20.93M | 33.14M | 35.61M | 5.47M |
Free Cash Flow | -33.54M | -33.32M | -35.26M | -32.1M | -28.32M | -24.14M | -21.96M | -20.65M | -18.96M | -18.17M | -16.48M | -13.82M | -10.67M | -9.36M | -7.77M | -6.78M |